Samples from the patient in Louisiana, who was recently hospitalized with the first severe case of H5N1 bird flu in the country, have undergone a genetic analysis. The findings indicate that the virus likely mutated within the patient, potentially increasing its transmissibility to humans. However, there is no evidence to suggest that the virus has been transmitted to others.
According to the US Centers for Disease Control and Prevention, the patient was probably exposed to the virus through contact with sick and deceased birds in a backyard flock. The agency mentioned in an earlier statement that mutations detected in samples collected during the patient’s hospitalization were not present in the birds, indicating that these mutations are not part of the virus circulating widely in wildlife.
The mutations observed in the Louisiana patient are similar to those identified in a patient hospitalized in British Columbia, Canada. These mutations could potentially enhance the virus’s ability to attach to cell receptors in the upper respiratory tracts of humans, as outlined in the agency’s analysis.
“The changes observed were likely generated by replication of this virus in the patient with advanced disease rather than primarily transmitted at the time of infection,” the CDC said. “Although concerning, and a reminder that A(H5N1) viruses can develop changes during the clinical course of a human infection, these changes would be more concerning if found in animal hosts or in early stages of infection… when these changes might be more likely to facilitate spread to close contacts.”
A genetic analysis of samples of the bird flu virus from a Louisiana patient show the virus likely mutated in the patient to potentially become more transmissible to humans.
CDC/NIAID/AP via CNN Newsource
The agency emphasized the risk to the general public has not changed and remains low, but said the detection of the genetic mutations “underscores the importance of ongoing genomic surveillance in people and animals, containment of avian influenza A(H5) outbreaks in dairy cattle and poultry, and prevention measures among people with exposure to infected animals or environments.”
The analysis found no changes associated with markers that might mean antiviral drugs wouldn’t work as well against the virus, the CDC added, and noted the samples are closely related to strains that could be used to make vaccines, if needed.
The sequences also didn’t show changes in genes associated with adaptation to mammals, the CDC found. The patient was infected with a strain known as D1.1 that’s closely related to viruses circulating in wild birds and poultry in the U.S.; another strain known as B3.13 has been spreading widely in dairy cows and hasn’t been found to cause severe disease in humans in the U.S.
“While this sounds like good news, the H5N1 situation remains grim,” Dr. Angela Rasmussen, a virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada, posted on Bluesky on Thursday.
“There has been an explosion of human cases,” she said. “We don’t know what combination of mutations would lead to a pandemic H5N1 virus… but the more humans are infected, the more chances a pandemic virus will emerge.”
The CDC has confirmed 65 cases of H5N1 bird flu in humans in 2024. Of those, 39 were associated with dairy herds and 23 with poultry farms and culling operations. For two cases, the source of exposure is unknown. The severe case in the Louisiana is the only one associated with backyard flocks.
Dr. Paul Offit, a vaccine scientist at Children’s Hospital of Philadelphia, noted the CDC said the mutations “may” enable to the virus to bind better to cell receptors in humans’ upper respiratory tracts, not that they clearly do.
“I’d like to see clear evidence… that it binds well,” Offit told CNN Friday. “That hasn’t happened yet.”
“And more importantly,” Offit added, “there’s not the clinical relevance that you see human-to-human spread.”
